Eris Lifesciences Ltd ERIS-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 8:48 AM IST
580.30quote price arrow up+5.75 (+1.00%)
Volume
2,819
52 week range
321.00 - 643.20

...

Loading . . .

KEY STATS

  • Open576.00
  • Day High580.90
  • Day Low576.00
  • Prev Close574.55
  • 52 Week High643.20
  • 52 Week High Date01/20/21
  • 52 Week Low321.00
  • 52 Week Low Date03/13/20
  • Market Cap1,067.21M
  • Shares Out135.78M
  • 10 Day Average Volume165,495.8
  • Dividend8.37
  • Dividend Yield1.44%
  • Beta
  • 1 Year % Change33.26

RATIOS/PROFITABILITY

  • EPS (TTM)25.26
  • P/E (TTM)22.97
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date08/13/2020
  • Div Amount5.50
  • Split Date-
  • Split Factor-

Latest Eris Lifesciences Ltd News

There is no recent news for this security.

Latest ERIS-IN News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Eris Lifesciences Limited is an India-based company, which is engaged in manufacturing, marketing and selling of generics within the chronic and acute categories of the Indian Pharmaceutical Market. The Company operates within various areas through its seven focused divisions: Eris, Nikkos, Adura, Montana, Inspira, Victus, Eris Kinedex, Eterna, and Altiza. Its Eris division includes Atorsave 10, Atorsave 20, Decal, Enoxsave 0.6 and Metaloc XL100 products; its Nikkos division...
Amit Bakshi
Chairman
Sachin Shah
Chief Financial Officer
Address
7th Floor, Commerce House IV,,
Beside Shell Petrol Pump, 100 Feet Road,
Ahmedabad
380015
India